Omicron in the US: What You Need to Know (with Scott Gottlieb)
In the Bubble with Andy Slavitt
00:00
Vaccines
i think that the policy environments a changed. And there's sort of anxther's demand that, you know, you you make the ip available and and try to put it into markets and allow them to develop themselves sufficient supply. The other is that manufacturing of orally available protese in the hibotar is very different than manufacturing an m r and a vaxine. We'll see if the u. N and wh are able to actually scale up manufacturing effectively. Hopefully they are, because i think a lot of countries dependent upon him. Fisers obviously still available to manufacture his an untry to back stop that.
Transcript
Play full episode
